The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6)
- 29 March 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (7), 1151-1156
- https://doi.org/10.1016/0006-2952(94)90386-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- On the Metabolism of 3,4-Methylenedioxymethamphetamine (MDMA) in ManTherapeutic Drug Monitoring, 1993
- Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeastBiochemical Pharmacology, 1992
- Enzymic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomesChemical Research in Toxicology, 1992
- Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuseThe Lancet, 1992
- Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl]propane [(methylenedioxy)methamphetamine]Chemical Research in Toxicology, 1992
- Molecular genetics of the debrisoquin-sparteine polymorphismClinical Pharmacology & Therapeutics, 1991
- Chronic paranoid psychosis after misuse of MDMA.BMJ, 1991
- Direct central effects of acute methylenedioxymethamphetamine on serotonergic neuronsEuropean Journal of Pharmacology, 1988
- 'Eve' and 'Ecstasy'JAMA, 1987
- Conformational study of catechol amine receptor sites. 7. Syntheses of erythro-and threo-3-amino-2-(3,4-dihydroxyphenyl)-2-butanol hydrochlorides and erythro- and threo-2-amino-3-(3,4-dihydroxyphenyl)butanehydrochloridesJournal of Medicinal Chemistry, 1971